Bumetanide, >=98%

Code: b3023-1g D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Inhibitor of Na+/K+/Cl- cotransporter.

Features and Benefits

This compound was developed...


read more

Your Price
$723.30 1G
REQUEST

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Inhibitor of Na+/K+/Cl- cotransporter.

Features and Benefits

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Other Notes

Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. B3023.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

assay≥98%
formpowder
Gene Informationhuman ... SLC12A1(6557)
InChI keyMAEIEVLCKWDQJH-UHFFFAOYSA-N
InChI1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)
originatorRoche
Quality Level100
SMILES stringCCCCNc1cc(cc(c1Oc2ccccc2)S(N)(=O)=O)C(O)=O
Code
Description
Unit Size
List Price
Qty
B3023-250MG
Bumetanide, >=98%

Unit:250MG
List Price: $223.85
Source:List Price
ADD
Cas Number28395-03-1
This product has met the following criteria: